Paclitaxel 300 mg Injection Mitotax
Trade Name: Mitotax
Manufacturer: Dr Reddy’s Laboratories Ltd
What is the purpose of Paclitaxel 300 mg injection?
Paclitaxel 300 mg injection (with polyoxyethylated castor oil) is used to treat breast cancer, ovarian cancer (cancer that starts in the female reproductive organs where eggs are generated), and non-small cell lung cancer either by itself or in conjunction with other chemotherapeutic medicines (NSCLC).
What sorts of cancers are treated with paclitaxel?
Paclitaxel is a kind of chemotherapy. It’s used to treat ovarian, breast, and non-small cell lung cancer, among other cancers. Other cancers, including as stomach cancer, may also be treated with it.
Is paclitaxel given as a shot?
The injection of paclitaxel is used to treat advanced ovarian cancer, breast cancer, non-small cell lung cancer, and Kaposi sarcoma. Kaposi sarcoma is a skin and mucous membrane cancer that is frequently observed in people who have acquired immunodeficiency syndrome (AIDS).
What are the paclitaxel side effects?
- It is possible to experience nausea
- mouth sores
- muscle/joint discomfort
- numbness/tingling/burning of the hands/feet
- Contact your doctor right away if any of these side effects persist or worsen. It’s possible that you’ll lose some hair temporarily. Normal hair growth should continue after the operation.
- For more details Click Here.
When do the side effects of paclitaxel appear?
After receiving Paclitaxel, you may have a fever, face flushing, chills, shortness of breath, or hives (see allergic reaction). Within the first 10 minutes of an infusion, the majority of these reactions occur.
Is it possible for paclitaxel to induce lung problems?
Paclitaxel is a neoadjuvant chemotherapy medication that is regularly used. Multi-course paclitaxel treatment has been linked to lung damage such as pulmonary alveolar-capillary leakage in previous investigations.
How effective is paclitaxel?
Many of the participants in these studies had previously undergone chemotherapy. Nonetheless, single-agent therapy with weekly paclitaxel has obtained response rates of up to 86 percent, combination therapy has achieved response rates of up to 87 percent, and radiation has achieved response rates of up to 100 percent.
If you are looking for another product or brand click here.